Natriuretic hormones, endogenous ouabain, and related sodium transport inhibitors

Frontiers in Endocrinology

Volumn 5, Issue DEC, 2014, Pages

  Hamlyn, John M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Excretion; Hormone; Ouabain; Salt; Sodium; Sodium pump; Urine

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BUFADIENOLIDE; BUFOGENIN; CARDIOTONIC AGENT; CARDIOTONIC STEROID; CHYMOTRYPSIN; DIGOXIN; DIGOXIN ANTIBODY F(AB) FRAGMENT; DOPAMINE RECEPTOR BLOCKING AGENT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GUANYLIN; INTERMEDIN; MARINOBUFAGENIN; MINERALOCORTICOID; NATRIURETIC FACTOR; OUABAIN; OXYTOCIN; PROLINE DIPEPTIDASE; SEPHADEX; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG; URODILATIN; UROGUANYLIN; VASOPRESSIN; VASOPRESSIN V1 RECEPTOR; XANTHURENIC ACID;

BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DEHYDRATION; DIURETIC ACTIVITY; GLOMERULUS FILTRATION RATE; HUMAN; HYPONATREMIA; HYPOPHYSECTOMY; NATRIURESIS; NONHUMAN; OSMOLARITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SODIUM BALANCE; SODIUM EXCRETION; SODIUM TRANSPORT;

EID: 84920161337     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00199     Document Type: Review

References (200)

1. de Wardener HE, Clarkson EM. Concept of natriuretic hormone. Physiol Rev (1985) 65:658-759.
2. Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol (2009) 38(3):791-813. doi: 10.1093/ije/dyp139
3. Wechter WJ, Kantoci D, Murray ED Jr, D'Amico DC, Jung ME, Wang WH. A new endogenous natriuretic factor: LLU-alpha. Proc Natl Acad Sci USA (1996) 93(12):6002-7. doi:10.1073/pnas.93.12.6002
4. Selkert EE. Sodium excretion by the mammalian kidney. Physiol Rev (1954) 34:287-333.
5. Slatopolsky E, Elkan IO, Weerts C, Bricker NS. Studies on the characteristics of the control system governing sodium excretion in uremic man. J Clin Invest (1968) 47:521-30. doi:10.1172/JCI105877
6. de Wardener HE, Mills IH, Clapham WF, Hayter CJ. Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci (1961) 21:249-58.
7. Bahlman JS, McDonald J, Ventom MG, de Wardener HE. The effect on urinary sodium excretion of blood volume expansion without changing the composition of the blood. Clin Sci (1967) 32:403-13.
8. Tobian L, Coffee K, McCrea P. Evidence for a humoral factor of non-renal and non-adrenal origin which influences sodium excretion. Trans Assoc Am Physicians (1967) 80:200-6.
9. Kaloyanides GJ, Azer M. Evidence of a humoral mechanism in volume expansion natriuresis. J Clin Invest (1971) 50:1603-12. doi:10.1172/JCI106648
10. Knock CA. Further evidence in vivo for a circulating natriuretic substance after expanding the blood volume in rats. Clin Sci (1980) 59:423-33.
11. Goetz KL. Physiology and pathophysiology of atrial peptides. Am J Physiol (1988) 254:E1-15.
12. Goetz KL. Evidence that atriopeptin is not a physiological regular of sodium excretion. Hypertension (1990) 15:9-19. doi:10.1161/01.HYP.15.1.9
13. Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens (2008) 21(7):733-41. doi:10.1038/ajh.2008.174
14. De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci (1981) 28:89-94. doi:10.1016/0024-3205(81)90370-2
15. Richards AM, McDonald D, Fitzpatrick MA, Nicholls MG, Espiner EA, Ikram H, et al. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab (1988) 67(6):1134-9. doi:10.1210/jcem-67-6-1134
16. Anderson JV, Struthers AD, Christofides ND, Bloom SR. Atrial natriuretic peptides: an endogenous factor enhancing sodium excretion in man. Clin Sci (1986) 70:327-31.
17. Lang RE, Tholken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor -a circulating hormone stimulated by volume loading. Nature (1985) 314:264-6. doi:10.1038/314264a0
18. Richards AM, Tonolo G, Polonia J, Montorsi P. Contrasting plasma atrial natriuretic factor concentrations during comparable natriuresis with infusions of atrial natriuretic factor and saline in normal man. Clin Sci (Lond) (1988) 75(5):455-62.
19. Goetz KL, Wang BC, Geer PG, Leadley RJ Jr, Reinhardt HW. Atrial stretch increases sodium excretion independently of release of atrial peptides. Am J Physiol (1986) 250:R946-50.
20. Goetz KL, Wang BC, Geer PG, Sundet WD, Needleman P. Effects of atriopeptin infusion versus effects of left atrial stretch in awake dogs. Am J Physiol (1986) 250:R221-6.
21. Goetz KL, Wang BC, Bie P, Leadley RJ, Geer PG. Natriuresis during atrial distension and a concurrent decline in plasma atriopeptin. Am J Physiol (1988) 255:R259-67.
22. Wechter WJ, Benaksas EJ. Natriuretic hormones. Prog Drug Res (1990) 34:231-60.
23. De Bold AJ. On the shoulders of giants: the discovery of atrial natriuretic factor. Can J Physiol Pharmacol (1987) 65(10):2007-12. doi:10.1139/y87-314
24. Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG. Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr (1988) 66(17):752-9. doi:10.1007/BF01726570
25. Cain CD, Schroeder FC, Shankel SW, Mitchnick M, Schmertzler M, Bricker NS. Identification of xanthurenic acid 8-O-beta-d-glucoside and xanthurenic acid 8-O-sulfate as human natriuretic hormones. Proc Natl Acad Sci U S A (2007) 104(45):17873-8. doi:10.1073/pnas.0705553104
26. Currie MG, Fok KF, Kato J, Moore RJ, Hamra FK, Duffin KL, et al. Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc Natl Acad Sci U S A (1992) 89:947-51. doi:10.1073/pnas.89.3.947
27. Hamra FK, Forte LR, Eber SL, Pidhorodeckyj NV, Krause WJ, Freeman RH, et al. Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc Natl Acad Sci USA (1993) 90:10464-8. doi:10.1073/pnas.90.22.10464
28. Veress AT, Pearce JW, Solomon S. The effect of acute adrenalectomy on volume natriuresis in the rat. Proc Soc Exp Biol Med (1974) 145(2):533-6. doi:10.3181/00379727-145-37846
29. Kaloyanides GJ, Cohen L, DiBona GF. Failure of selected end organ ablation to modify the natriuresis of blood volume expansion in the dog. Clin Sci Mol Med (1977) 52:351-6.
30. Schneider R, Wray V, Nimtz M, Lehmann WD, Kirch U, Antolovic R, et al. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J Biol Chem (1998) 273(2):784-92. doi:10.1074/jbc.273.2.784
31. Kramer HJ, Gonick HC. Effect of extracellular volume expansion on renal Na, K-ATPase and cell metabolism. Nephron (1974) 12:281-96. doi:10.1159/000180341
32. Kramer HJ. Natriuretic activity in plasma following extracellular volume expansion. In: Kauffman W, Krause DK, editors. Central Nervous Control of Na+ Balance-Relations to the Renin-Angiotensin System. Stuttgart: Georg Thieme Verlag (1976). p. 126-35.
33. Sedlakova E, Lichardus B, Cort JH. Plasma saluretic activity: its nature and relation to oxytocin analogues. Science (1969) 164:580-92. doi:10.1126/science.164.3879.580
34. Kramer HJ, Rietzel C, Klingmuller D, Dusing R. Further studies on the isolation and purification of a small molecular weight natriuretic hormone. In: Lichardus B, Schrier RW, Ponec J, editors. Hormonal Regulation of Sodium Excretion. North Holland: Elsevier (1980). p. 313-22.
35. Buckalew VM Jr, Nelson DB. Natriuretic and sodium transport inhibitory activity in plasma of volume-expanded dogs. Kidney Int (1974) 5:12-22. doi:10.1038/ki.1974.2
36. Sealey JE, Kirshman JD, Laragh JH. Natriuretic activity in plasma and urine of salt-loaded man and sheep. J Clin Invest (1969) 48:2210-24. doi:10.1172/JCI106187
37. Gruber KA, Whitaker JM, Buckalew VM Jr. Endogenous digitalis-like substance in plasma of volume expanded dogs. Nature (1980) 287:743-5. doi:10.1038/287743a0
38. Bourgoignie JJ, Hwang KH, Espinel C, Klahr S, Bricker NS. A natriuretic factor in the serum of patients with chronic uremia. J Clin Invest (1972) 51:1514-27. doi:10.1172/JCI106948
39. Bourgoignie JJ, Weisser F, Rolf D, Klahr S, Bricker NS. Demonstration of a low molecular weight natriuretic factor in uremic serum. Trans Assoc Am Physicians (1970) 83:277-87.
40. Bourgoignie JJ, Klahr S, Bricker NS. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum. J Clin Invest (1971) 50:303-11. doi:10.1172/JCI106495
41. Bourgoignie JJ, Hwang KH, Ipakchi EJ, Bricker NS. The presence of a natriuretic factor in the urine of patients with chronic uremia. J Clin Invest (1974) 53:1559-67. doi:10.1172/JCI107706
42. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, et al. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA (1991) 88(14):6259-63. doi:10.1073/pnas.88.21.9907-d
43. Kawamura A, Guo J, Itagaki Y, Bell C, Wang Y, Haupert GT Jr, et al. On the structure of endogenous ouabain. Proc Natl Acad Sci U S A (1999) 96(12):6654-9. doi:10.1073/pnas.96.12.6654
44. Forte LR, Fan X, Hamra FK. Salt and water homeostasis: uroguanylin is a circulating peptide hormone with natriuretic activity. Am J Kidney Dis (1996) 28(2):296-304. doi:10.1016/S0272-6386(96)90318-2
45. Cambier P, Godon JP. Role of prostaglandins in the production of natriuretic factor by the isolated rat kidney. Ren Physiol (1984) 7(3):163-75.
46. Godon JP, Nizet A. Release by isolated dog kidney of a natriuretic material following saline loading. Arch Int Physiol Biochim (1974) 82:309-11. doi:10.3109/13813457409070478
47. Gonick HJ, Saldanha LF. A natriuretic principle derived from kidney tissue of volume expanded rats. J Clin Invest (1975) 56:247-55. doi:10.1172/JCI108087
48. Louis F, Favre H. Basal activity of the natriuretic factor extracted from the rat kidney as a function of the diet and its role in the regulation of the acute sodium balance. Clin Sci (1980) 58:385-91.
49. Drummer C, Fiedler F, König A, Gerzer R. Urodilatin, a kidney-derived natriuretic factor, is excreted with a circadian rhythm and is stimulated by saline infusion in man. J Am Soc Nephrol (1991) 1(9):1109-13.
50. Feller SM, Gagelmann M, Forssmann WG. Urodilatin: a newly described member of the ANP family. Trends Pharmacol Sci (1989) 10(3):93-4. doi:10.1016/0165-6147(89)90199-5
51. Ivanov YI. The evidence of production or activation of a natriuretic factor in the liver. Endocrinol Exp (1979) 13:195-200.
52. Milies E. A new diuretic factor of hepatic origin. Acta Physiol Lat Am (1959) 10:178-93.
53. Zubiaur M, Fernandez Munoz MD, Hernando L, Lopez-Novoa JM. Role of the natriuretic hormone in the specific natriuresis induced by intraportal infusion of hypertonic saline in dogs. Miner Electrolyte Metab (1987) 13:13-8.
54. Sealey JE, Laragh JH. Further studies of a natriuretic substance occurring in human urine and plasma. Circ Res (1971) 28(Suppl II):II32-43. doi:10.1161/01.RES.28.5.II-32
55. Passo SS, Thornborough JR, Rothballer AB. Hepatic receptors in the control of sodium excretion in anesthetized cats. Am J Physiol (1973) 224:373-5.
56. Perlmutt JH, Aziz O, Haberich FJ. A comparison of sodium excretion in response to infusion of isotonic saline into the vena porta and vena cava of conscious dogs. Pflugers Arch (1975) 357:1-14. doi:10.1007/BF00584540
57. Daly JJ, Roe JW, Horrocks P. A comparison of sodium excretion following the infusion of saline into systemic and portal veins in the dog: evidence for a hepatic role in the control of sodium excretion. Clin Sci (1967) 33:481-7.
58. Potkay S, Gilmore JP. Renal response to vena cava and portal venous infusions of sodium chloride in unanesthetized dogs. Clin Sci (1970) 39:13-20.
59. Strandhoy JW, Williamson HE. Evidence for an hepatic role in the control of sodium excretion. Proc Soc Exp Biol Med (1970) 133:419-22. doi:10.3181/00379727-133-34487
60. Clarkson EM, Raw SM, de Wardener HE. Further observations on a low-molecular weight natriuretic substance in the urine of normal man. Kidney Int (1979) 16:710-21. doi:10.1038/ki.1979.187
61. Clarkson EM, Young DR, Raw SM, de Wardener HE. Chemical properties, physiological action and further separation of a low molecular weight natriuretic substance in the urine of normal man. In: Lichardus B, Schrier RW, Ponec J, editors. Hormonal Regulation of Sodium Excretion. North Holland: Elsevier (1980). p. 333-40.
62. Fine LG, Bourgoignie JJ, Hwang KH, Bricker NS. On the influence of the natriuretic factor from patients with chronic uremia on the bioelectric properties and sodium transport of the isolated mammalian collecting tubule. J Clin Invest (1976) 58(3):590-7. doi:10.1172/JCI108505
63. Clarkson EM, Raw SM, de Wardener HE. Two natriuretic substances in extracts of urine from normal man when salt-depleted and salt-loaded. Kidney Int (1976) 10:381-94. doi:10.1038/ki.1976.124
64. Kruck F. Influence of humoral factors on renal tubular sodium handling. Nephron (1969) 6:205-16. doi:10.1159/000179729
65. Viskoper JR, Czaczkeo JW, Schwartz N, Ullmann TD. Natriuretic activity of a substance isolated from human urine during the excretion of a salt load. Nephron (1971) 8:540-8. doi:10.1159/000179959
66. Bagrov AY, Fedorova OV, Dmitrieva RI, Howald WN, Hunter AP, Kuznetsova EA, et al. Characterization of a urinary bufodienolide Na+, K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension (1998) 31:1097-103. doi:10.1161/01.HYP.31.5.1097
67. Hoffman A, Okun-Gurevich M, Ovcharenko E, Goltsman I, Karram T, Cain C, et al. Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-ß-d-glucoside in rats. Physiol Rep (2013) 1(6):e00155. doi:10.1002/phy2.155
68. Eliades D, Pamnani MB, Swindall BT, Haddy FJ. Effects of bufalin on renal venous outflow, urine flow and natriuresis in the anesthetized dog. Adv Exp Med Biol (1991) 308:205-10. doi:10.1007/978-1-4684-6015-5_17
69. Pamnani MB, Chen S, Bryant HJ, Schooley JF Jr, Eliades DC, Yuan CM, et al. Effects of three sodium-potassium adenosine triphosphatase inhibitors. Hypertension (1991) 18(3):316-24. doi:10.1161/01.HYP.18.3.316
70. Bagrov AY, Shapiro JI, Fedorova OV. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev (2009) 61(1):9-38. doi:10.1124/pr.108.000711
71. Hamlyn JM, Ludens JH. Nonatrial natriuretic hormones. In: Seldin DW, Giebisch G, editors. The Kidney, Physiology and Pathophysiology. New York, NY: Raven Press (1992). p. 1885-924.
72. Alberola A, Pinilla JM, Quesada T, Romero JC, Salom MG, Salazar FJ. Role of nitric oxide in mediating renal response to volume expansion. Hypertension (1992) 19(6 Pt 2):780-4. doi:10.1161/01.HYP.19.6.780
73. Coruzzi P, Novarini A, Musiari L, Ravanetti C, Ghielmi S, Rodella A, et al. The antinatriuretic effect of dopaminergic blockade during volume expansion is independent of circulating atrial natriuretic factor. Clin Sci (Lond) (1989) 77(5):479-84.
74. Hansell P, Sjoquist M, Fasching A, Isaksson B, Karlsson M, Ulfendahl HR. CNS-induced natriuresis during dopamine receptor blockade. Further support for the existence of, at least, two separate natriuretic hormonal systems. Acta Physiol Scand (1988) 133:373-80. doi:10.1111/j.1748-1716.1988.tb08419.x
75. Jose PA, Holloway RR, Campbell TW, Eisner GM. Dopamine blockade attenuates the natriuresis of saline loading in the adrenalectomized rat. Nephron (1988) 48:54-7. doi:10.1159/000184869
76. McClanahan M, Sowers JR, Beck FWJ, Mohanty PK, McKenzie T. Dopaminergic regulation of natriuretic response to acute volume expansion in dogs. Clin Sci (1985) 68:263-9.
77. Hegde S, Jadhav AL, Lokhandwala MF. Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension (1989) 13:828-34. doi:10.1161/01.HYP.13.6.828
78. Buckalew VM Jr, Adkins TG. Effects of interrupting intravenous saline infusion on sodium excretion in the dog. Ren Physiol (1978) 1:11-8.
79. Andersson B, Jobin M, Olsson K. Stimulation of urinary salt excretion following injections of hypertonic NaCl solution into the 3rd brain ventricle. Acta Physiol Scand (1966) 67:127-8. doi:10.1111/j.1748-1716.1966.tb03293.x
80. Andersson B, Dallman MF, Olsson K. Evidence for a hypothalamic control of renal sodium excretion. Acta Physiol Scand (1969) 75:496-510. doi:10.1111/j.1748-1716.1969.tb04403.x
81. Andersson B, Westbye O. Synergistic action of sodium and angiotension on brain mechanisms controlling fluid balance. Life Sci (1970) 9:601-8. doi:10.1016/0024-3205(70)90090-1
82. Blaine E, Denton DA, McKinley MJ, Weller S. A central osmosensitive receptor for renal sodium excretion. J Physiol (1975) 244:497-509.
83. Morris M, McCann SM, Orias R. Evidence for hormonal participation in the natriuretic and kaliuretic responses to intraventricular hypertonic saline and norepinephrine. Proc Soc Exp Biol Med (1976) 152:95-8. doi:10.3181/00379727-152-39336
84. McKinley MJ, Denton DA, Coghlan JP, Harvey RB, McDougall JG, Rundgren M, et al. Cerebral osmoregulation of renal sodium excretion-a response analogous to thirst and vasopressin release. Can J Physiol Pharmacol (1987) 65:1724-9. doi:10.1139/y87-271
85. Thornborough JR, Passo SS, Rothballer AB. Receptors in cerebral circulation affecting sodium excretion in the cat. Am J Physiol (1973) 225(1):138-41.
86. Andersson B, Jobin M, Olsson K. A study of thirst and other effects of an increased sodium concentration in the 3rd brain ventricle. Acta Physiol Scand (1967) 69(1):29-36. doi:10.1111/j.1748-1716.1967.tb03488.x
87. Mouw DR, Vander AJ. Evidence for brain Na receptors controlling renal Na excretion and plasma renin activity. Am J Physiol (1970) 219:822-32.
88. Ulfendahl HR, Goransson A, Hansell P, Karlsson M, Sjoquist M. Natriuresis obtained by stimulation of the cerebroventricular system with sodium ions indicates a blood bourne natriuretic factor. Acta Physiol Scand (1986) 127:269-71. doi:10.1111/j.1748-1716.1986.tb07904.x
89. Saville MA, Geer PG, Wang BC, Leadley RJ, Goetz KL. A high-salt meal produces natriuresis in humans without elevating plasma atriopeptin. Proc Soc Exp Biol Med (1988) 188:387-93. doi:10.3181/00379727-188-3-RC2
90. Hansell P, Goransson A, Leppaluoto J, Arjamaa O, Vakkurri O, Ulfendahl HR. CNS-induced natriuresis is not mediated by the atrial natriuretic factor. Acta Physiol Scand (1987) 129:221-7. doi:10.1111/j.1748-1716.1987.tb08062.x
91. Hansell P. Natriuretic factors. Influence on glomerular filtration, renal blood flow and electrolyte excretion in the rat. Acta Univ Ups (1988) 154:1-29.
92. Ulfendahl HR, Ahlsson A, Hansell P, Hoglund U, Jacobsson E, Lee SL, et al. Studies on the mechanisms underlying CNS-induced natriuresis. Acta Physiol Scand (1989) 136(Suppl 583):75-8.
93. Leksell LG, Congiu M, Denton DA, Fei DT, McKinley MJ, Tarjan E, et al. Influence of mannitol-induced reduction in CSF Na on nervous and endocrine mechanisms involved in the control of fluid balance. Acta Physiol Scand (1981) 112(1):33-40. doi:10.1111/j.1748-1716.1981.tb06779.x
94. Leksell LG, Denton DA, Fei DT, McKinley MJ, Müller AF, Weisinger RS, et al. On the importance of CSF Na in the regulation of renal sodium excretion and renin release. Acta Physiol Scand (1982) 115(1):141-6. doi:10.1111/j.1748-1716.1982.tb07056.x
95. McKinley MJ, Denton DA, Fryday HW, Weisinger RS. Cerebral mechanisms influencing renal sodium excretion in dehydrated sheep. Clin Exp Pharmacol Physiol (1983) 10:521-6. doi:10.1111/j.1440-1681.1983.tb00220.x
96. McKinley MJ, Evered MD, Mathai ML. Renal Na excretion in dehydrated and rehydrated adrenalectomized sheep maintained with aldosterone. Am J Physiol Regul Integr Comp Physiol (2000) 279(1):R17-24.
97. Cox PS, Denton DA, Mouw DR, Tarjan E. Natriuresis induced by localized perfusion within the third cerebral ventricle of sheep. Am J Physiol (1987) 252:R1-6.
98. Cort JH, Lichardus B. The natriuretic activity of jugular vein blood during carotid occlusion. Physiol Bohemoslov (1963) 12:497-501.
99. Andersson B, Lishajko F, Leskell LG. Perturbations in fluid balance induced by medially placed forebrain lesions. Brain Res (1975) 99:261-75. doi:10.1016/0006-8993(75)90028-1
100. Keeler R. Effect of chronic preoptic lesions on the renal excretion of sodium in rats. Am J Physiol (1975) 228:1725-8.
101. Johnson AK, Buggy J. Periventricular preoptic-hypothalamus is vital for thirst and normal water economy. Am J Physiol (1978) 234:R122-9.
102. Kaloyanides GJ, Balabanian MB, Bowman RL. Evidence that the brain participates in the humoral natriuretic mechanism of blood volume expansion in the dog. J Clin Invest (1978) 62:1288-95. doi:10.1172/JCI109249
103. Bealer SL, Haywoood JR, Gruber KA, Buckalew VM Jr, Fink GD, Brody MJ. Preoptic-hypothalamic periventricular lesions reduce natriuresis to volume expansion. Am J Physiol (1983) 244:R51-7.
104. Mangiapane ML, Thrasher TN, Keil LC, Simpson JB, Ganong WF. Deficits in drinking and vasopressin secretion after lesions of the nucleus medianus. Neuroendocrinology (1983) 37:73-7. doi:10.1159/000123518
105. McKinley MJ, Congiu M, Denton DA, Park RG, Penschow J, Simpson JB, et al. The anterior wall of the third cerebral ventricle and homeostatic responses to dehydration. J Physiol (1984) 79:421-7.
106. McKinley MJ, Lichardus B, McDougall JG, Weisinger RS. Periventricular lesions block natriuresis to hypertonic but not isotonic NaCl loads. Am J Physiol (1992) 262(1 Pt 2):F98-107.
107. Peters JP, Welt LG, Simms EAH. A salt wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians (1950) 63:57-64.
108. Cort JH. Cerebral salt wasting. Lancet (1954) 1:752-4. doi:10.1016/S0140-6736(54)92715-4
109. Nelson PB, Seif SM, Maroon JC, Robinson AG. Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Neurosurg (1981) 55:938-41. doi:10.3171/jns.1981.55.6.0938
110. Nelson PB, Seif SM, Gutal J, Robinson AG. Hyponatremia and natriuresis following subarachnoid hemorrhage in a monkey model. J Neurosurg (1984) 60:233-7. doi:10.3171/jns.1984.60.2.0233
111. Diringer M, Ladenson PW, Borel C, Hart GK, Kirsch JR, Hanley DF. Sodium and water regulation in a patient with cerebral salt wasting. Arch Neurol (1989) 46:928-30. doi:10.1001/archneur.1989.00520440124031
112. McKinley MJ, Denton DA, Park RG, Weisinger RS. Cerebral involvement in dehydration-induced natriuresis. Brain Res (1983) 263:340-3. doi:10.1016/0006-8993(83)90326-8
113. Mouw DR, Vander AJ, Bourgoignie JJ, Kutschinski SS, Mathias NP. Nonpressor mechanisms in CNS-induced natriuresis. Am J Physiol (1979) 237:F157-66.
114. Luke RG. Natriuresis and chloruresis during hydropenia in the rat. Am J Physiol (1973) 224:13-20.
115. Pierce ET, Grekin RJ, Mouw DR. Efferent role of ADH in CNS-induced natriuresis. Am J Physiol (1984) 246:F32-8.
116. Mouw DR, Vander AJ, Landis C, Kutschinski S, Mathias N, Zimmerman D. Dose-response relation of CSF sodium and renal sodium excretion, and its absence in homozygous Brattleboro rats. Neuroendocrinology (1980) 30(4):206-12. doi:10.1159/000123002
117. Beasley D, Malvin RL, Mouw DR. CNS-induced natriuresis and renal hemodynamics in conscious rats. Am J Physiol (1983) 245:F763-71.
118. Humphreys MH, Friedler RM, Earley LE. Natriuresis produced by vasopressin or hemorrhage during water diuresis in the dog. Am J Physiol (1970) 219:658-64.
119. Fejes-Toth G, Magyar A, Walter J. Renal response to vasopressin after inhibition of prostaglandin synthesis. Am J Physiol (1977) 232:F416-23.
120. Balment RJ, Brimble MJ, Forsling ML, Musabayane CJ. Natriuretic response of the rat to plasma concentrations of arginine vasopressin within the physiological range. J Physiol (1984) 352:517-26.
121. Thrasher TN, Wade CE, Keil LC, Ramsay DJ. Sodium balance and aldosterone during dehydration and rehydration in the dog. Am J Physiol (1984) 247:R76-83.
122. Lote CJ, McVicar AJ, Smyth DG. Effects of vasopressin-glycine and vasopressin-glycine-lysine-arginine on renal function in the rat. J Endocrinol (1986) 108:255-60. doi:10.1677/joe.0.1080255
123. Lote CJ, Thewles A, Wood JA. Vasopressin-induced natriuresis in the conscious rat: role of blood pressure, renal prostaglandin synthesis and the peptide. Am J Physiol (1989) 411:481-91.
124. Park RG, Congiu M, Denton DA, McKinley MJ. Natriuresis induced by arginine vasopressin infusion in sheep. Am J Physiol (1985) 249:F799-805.
125. Merrill DC, Skelton MM, Cowley AW. Humoral control of water and electrolyte excretion during water restriction in sodium-deprived dogs. Kidney Int (1986) 29:1152-61. doi:10.1038/ki.1986.121
126. Beasley D, Malvin RL. Role of natriuretic factor in central nervous system (CNS)-induced natriuresis. Proc Soc Exp Biol Med (1985) 178:575-9. doi:10.3181/00379727-178-42044
127. Balment RJ, Brimble MJ, Forsling ML, Kelly LP, Musabayane CT. A synergistic effect of oxytocin and vasopressin on sodium excretion in the neurohypopysectomized rat. J Physiol (1986) 381:453-64.
128. Haller H, Bähr V, Bock A, Distler A, Philipp T. Vasopressin is increased in mineralocorticoid-induced blood pressure increase in man. J Hypertens (1987) 5(5):111-3.
129. Pennington GL, McKinley MJ. Reduction of cerebral NaCl concentration can abolish mineralocorticoid escape. Am J Physiol (1990) 259(5 Pt 2):F839-46.
130. Brooks DP, Share L, Crofton JT, Guthe C, Ling WD, Bohr DF. Increased sensitivity of the osmotic control of vasopressin in sheep with deoxycorticosterone acetate-induced hypertension. J Endocrinol (1985) 107(3):309-15. doi:10.1677/joe.0.1070309
131. Brooks FP, Pickford M. The effect of posterior pituitary hormones on the excretion of electrolytes in dogs. J Physiol (1958) 142:468-93.
132. Sawyer WH. Posterior pituitary extracts and excretion of electrolytes by the rat. Am J Physiol (1952) 169:583-7.
133. Chan WY, Sawyer WH. Saluretic action of neurohypophysial peptides in conscious dogs. Am J Physiol (1961) 201:799-803.
134. Bartter FC, Mills IH. The effect of oxytocin on sodium excretion. J Endocrinol (1969) 45(1):v-vi.
135. Kleinman LI, Banks RO. Natriuretic effect of oxytocin in saline-expanded neonatal dogs. Am J Physiol (1980) 239:F589-94.
136. Diez J, Colina I, Guarner F, Quiroga J, Corzo J, Purroy A, et al. Intracerebroventricular infusion of sodium chloride-rich artificial cerebrospinal fluid in rats induces natriuresis and releases an inhibitor of prostaglandin synthesis. Clin Sci (1984) 66:621-4.
137. Buckalew VM Jr, Dimond KA. Effect of vasopressin on sodium excretion and plasma antinatriferic activity in the dog. Am J Physiol (1976) 231:28-33.
138. Schwartzman M, Ferreri NR, Carroll MA, Songu-Mize E, McGiffJC. Renal cytochrome P450-related arachidonate metabolite inhibits Na, K-ATPase. Nature (1985) 314:620-2. doi:10.1038/314620a0
139. Gilmore JP, Nemeh MN. Salt depletion inhibits cerebral-induced natriuresis in the dog. Am J Physiol (1984) 247:F725-8.
140. Grim CE, Scoggins BA. The rapid adjustment of renal sodium excretion to changes in dietary sodium intake in sheep. Life Sci (1986) 39:215-22. doi:10.1016/0024-3205(86)90533-3
141. Lichardus B, Ponec J. On the role of the hypophysis in the mechanism of body fluid volume regulation in acutely hypophysectomized rats. Endokrinologie (1973) 61:403-12.
142. Clarkson EM, Koutsaimanis KG, Davidman M, DuBois M, Penn WP, deWardener HE. The effects of brain extracts on urinary sodium excretion of the rat and the intracellular sodium concentration of renal tubule fragments. Clin Sci Mol Med (1974) 41:210-3.
143. Sedlakova E, Prusik Z, Skopkova J, Barth T, Kluh I, Cort JH. Isolation of a tridecapeptide from natriuretic fractions of bovine posterior pituitary. Eur J Clin Invest (1974) 4:285-92. doi:10.1111/j.1365-2362.1974.tb00405.x
144. Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev (1992) 44(3):377-99.
145. Schoner W. Endogenous digitalis-like factors. Clin Exp Hypertens A (1992) 14(5):767-814. doi:10.3109/10641969209036220
146. de Wardener HE, MacGregor GA, Clarkson EM, Alaghband-Zadeh J, Bitensky L, Chayen J. Effect of sodium intake on ability of human plasma to inhibit renal Na, K-ATPase. Lancet (1981) i:411-2. doi:10.1016/S0140-6736(81)91792-X
147. Dikstein S. Stimulability, adenosine triphosphatases, and their control by cellular redox processes. Naturwissenschaften (1971) 58:439-43. doi:10.1007/BF00624617
148. Fenton S, Clarkson E, MacGregor G, Alaghband-Zadeh J, de Wardener HE. An assay of the capacity of biological fluids to stimulate renal glucose-6-phosphate dehydrogenase activity in vitro as a marker of their ability to inhibit sodium potassium-dependent adenosine triphosphatase activity. J Endocrinol (1982) 94(1):99-110. doi:10.1677/joe.0.0940099
149. Lichardus B, Ponec J. Conditions for biological evidence of a natriuretic hormone in experiments with rat cross circulation. Physiol Bohemoslov (1970) 19:330.
150. Nutbourne DM, Howse JD, Schrier RW, Talner LB, Ventom MG, Verroust PJ, et al. The effect of expanding the blood volume of a dog on the short circuit current across an isolated frog skin incorporated in the dogs circulation. Clin Sci (1970) 38:629-48.
151. Clarkson EM, Talner LB, de Wardener HE. The effect of plasma from blood volume expanded dogs on sodium, potassium and PAH transport of renal tubule fragments. Clin Sci (1970) 38:617-27.
152. Buckalew VM Jr, Lancaster CD Jr. Studies of a humoral sodium transport in normal dogs and dogs with ligation of the inferior vena cava. Circ Res (1971) 28-29(Suppl II):II-44-II-52.
153. Epstein M. Cardiovascular and renal effects of head out water immersion in man. Circ Res (1976) 39:619-28. doi:10.1161/01.RES.39.5.619
154. Poston L, Wilkinson SP, Sewell R, Williams R. Sodium transport during natriuresis of volume expansion. A study using peripheral leucocytes. Clin Sci (1982) 63:243-5.
155. Jandhyala BS, Ansari AF. Elevation of sodium levels in the cerebral ventricles of anesthetized dogs triggers the release of an inhibitor of ouabain-sensitive sodium-potasium-ATPase into the circulation. Clin Sci (1986) 70:103-10.
156. Haddy FJ. Natriuretic hormone -the missing link in low renin hypertension? Biochem Pharmacol (1982) 31:3159-61. doi:10.1016/0006-2952(82)90544-5
157. Ludens JH, Clark MA, Kolbasa KP, Hamlyn JM. Digitalis-like factor and ouabain-like compound in plasma of volume-expanded dogs. J Cardiovasc Pharmacol (1993) 22(Suppl 2):S38-41. doi:10.1097/00005344-199322002-00014
158. Graves SW, Markides KE, Hollenberg NK. Application of supercritical fluid chromatography to characterize a labile digitalis-like factor. Hypertension (2000) 36(6):1059-64. doi:10.1161/01.HYP.36.6.1059
159. Buckalew VM Jr, Martinez FJ, Green WE. The effect of dialysates and ultrafiltrates of plasma of saline-loaded dogs on toad bladder sodium transport. J Clin Invest (1970) 49:926-35. doi:10.1172/JCI106312
160. Buggy J, Huot S, Pamnani M, Haddy F. Periventricular forebrain mechanisms for blood pressure regulation. Fed Proc (1984) 43(1):25-31.
161. Mathews WR, DuCharme DW, Hamlyn JM, Harris DW, Mandel F, Clark MA, et al. Mass spectral characterization of an endogenous digitalislike factor from human plasma. Hypertension (1991) 17(6 Pt 2):930-5. doi:10.1161/01.HYP.17.6.930
162. Komiyama Y, Nishimura N, Dong XH, Hirose S, Kosaka C, Masaki H, et al. Liquid chromatography mass spectrometric analysis of ouabainlike factor in biological fluid. Hypertens Res (2000) 23(Suppl):S21-7. doi:10.1291/hypres.23.Supplement_S21
163. Goto A, Yamada K, Yagi N, Hui C, Nagoshi H, Sasabe M, et al. Digitalis-like factors from human urine. J Cardiovasc Pharmacol (1993) 22(Suppl 2):S58-9. doi:10.1097/00005344-199322002-00019
164. Komiyama Y, Dong XH, Nishimura N, Masaki H, Yoshika M, Masuda M, et al. A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin Biochem (2005) 38(1):36-45. doi:10.1016/j.clinbiochem.2004.08.005
165. Komiyama Y, Nishimura N, Munakata M, Okuda K, Nishino N, Kosaka C, et al. Increases in plasma ouabainlike immunoreactivity during surgical extirpation of pheochromocytoma. Hypertens Res (1999) 22(2):135-9. doi:10.1291/hypres.22.135
166. Ferrandi M, Manunta P, Ferrari P, Bianchi G. The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complications. Front Biosci (2005) 10:2472-7. doi:10.2741/1711
167. Huang BS, Amin MS, Leenen FH. The central role of the brain in salt-sensitive hypertension. Curr Opin Cardiol (2006) 21(4):295-304. doi:10.1097/01.hco.0000231398.64362.94
168. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol (2007) 293(2):C509-36. doi:10.1152/ajpcell.00098.2007
169. Manunta P, Ferrandi M, Bianchi G, Hamlyn JM. Endogenous ouabain in cardiovascular function and disease. J Hypertens (2009) 27(1):9-18. doi:10.1097/HJH.0b013e32831cf2c6
170. Xie Z, Askari A. Na(+)/K(+)-ATPase as a signal transducer. Eur J Biochem (2002) 269(10):2434-9. doi:10.1046/j.1432-1033.2002.02910.x
171. Drake MT, Violin JD, Whalen EJ, Wisler JW, Shenoy SK, Lefkowitz RJ. Beta-arrestin-biased agonism at the beta2-adrenergic receptor. J Biol Chem (2008) 283(9):5669-76. doi:10.1074/jbc. M708118200
172. Zulian A, Linde CI, Pulina MV, Baryshnikov SG, Papparella I, Hamlyn JM, et al. Activation of c-SRC underlies the differential effects of ouabain and digoxin on Ca(2+) signaling in arterial smooth muscle cells. Am J Physiol Cell Physiol (2013) 304(4):C324-33. doi:10.1152/ajpcell.00337.2012
173. Wilde WS, Howard PJ. Renal tubular action of ouabain on Na and K transport during stop-flow and slow-flow technique. J Pharmacol Exp Ther (1960) 130:232-8.
174. Yates NA, McDougall JG. Effects of direct renal arterial infusion of bufalin and ouabain in conscious sheep. Br J Pharmacol (1993) 108(3):627-30. doi:10.1111/j.1476-5381.1993.tb12852.x
175. Hook JB. A positive correlation between natriuresis and inhibition of renal Na, K-adenosine triphosphatase by ouabain. Proc Soc Exp Biol Med (1969) 13:731-4. doi:10.3181/00379727-131-33963
176. Selden R, Smith TW. Ouabain pharmacokinetics in dog and man: determination by radioimmunoassay. Circulation (1972) 45:1176-82. doi:10.1161/01.CIR.45.6.1176
177. Butler VP Jr, Schmidt DH, Smith TW, Haber E, Raynor BD, Demartini P. Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs. J Clin Invest (1977) 59(2):345-59. doi:10.1172/JCI108647
178. Cao Y, Zhao L, Liang Q, Bi K, Wang Y, Luo G. Study of the determination and pharmacokinetics of bufadienolides in dog's plasma after administration of Liu-Shen-Wan by high performance liquid chromatography time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 853(1-2):227-33. doi:10.1016/j.jchromb.2007.03.018
179. Zhang Y, Tang X, Liu X, Li F, Lin X. Simultaneous determination of three bufadienolides in rat plasma after intravenous administration of bufadienolides extract by ultra performance liquid chromatography electrospray ionization tandem mass spectrometry. Anal Chim Acta (2008) 610(2):224-31. doi:10.1016/j.aca.2008.01.029
180. Patel AR, Kurashina T, Granger JP, Kirchner KA. Acute Na+, K+-ATPase inhibition with bufalin impairs pressure natriuresis in the rat. Hypertension (1996) 27(3 Pt 2):668-71. doi:10.1161/01.HYP.27.3.668
181. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol (1998) 275(5 Pt 2):F633-50.
182. Doucet A, Barlet C. Evidence for differences in the sensitivity to ouabain of Na, K-ATPase along the nephrons of rabbit kidney. J Biol Chem (1986) 261:993-5.
183. Pittner J, Rhinehart K, Pallone TL. Ouabain modulation of endothelial calcium signaling in descending vasa recta. Am J Physiol Renal Physiol (2006) 291(4):F761-9. doi:10.1152/ajprenal.00326.2005
184. Bagrov AY, Fedorova OV. Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension. Front Biosci (2005) 10:2250-6. doi:10.2741/1694
185. Loreaux EL, Kaul B, Lorenz JN, Lingrel JB. Ouabain-Sensitive alpha1 Na, K-ATPase enhances natriuretic response to saline load. J Am Soc Nephrol (2008) 19(10):1947-54. doi:10.1681/ASN.2008020174
186. Doursout MF, Chelly JE, Liang YY, Buckley JP. The ouabain-dependent Na(+)-K+ pump and the brain renin-angiotensin system. Clin Exp Hypertens A (1992) 14(3):393-411. doi:10.3109/10641969209036197
187. Yuan CM, Manunta P, Hamlyn JM, Chen S, Bohen E, Yeun J, et al. Long-term ouabain administration produces hypertension in rats. Hypertension (1993) 22(2):178-87. doi:10.1161/01.HYP.22.2.178
188. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens (1994) 12(5):549-60. doi:10.1097/00004872-199405000-00008
189. Kurashina T, Kirchner KA, Granger JP, Patel AR. Chronic sodium-potassium-ATPase inhibition with ouabain impairs renal haemodynamics and pressure natriuresis in the rat. Clin Sci (Lond) (1996) 91(4):497-502.
190. Huang BS, Huang X, Harmsen E, Leenen FH. Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats. Hypertension (1994) 23(6 Pt 2):1087-90. doi:10.1161/01.HYP.23.6.1087
191. Zhang J, Lee MY, Cavalli M, Chen L, Berra-Romani R, Balke CW, et al. Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice. J Physiol (2005) 569(Pt 1):243-56. doi:10.1113/jphysiol.2005.091801
192. Cao C, Payne K, Lee-Kwon W, Zhang Z, Lim SW, Hamlyn J, et al. Chronic ouabain treatment induces vasa recta endothelial dysfunction in the rat. Am J Physiol Renal Physiol (2009) 296(1):F98-106. doi:10.1152/ajprenal.90429.2008
193. Blaustein MP, Leenen FH, Chen L, Golovina VA, Hamlyn JM, Pallone TL, et al. How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol (2012) 302(5):H1031-49. doi:10.1152/ajpheart.00899.2011
194. Manunta P, Hamilton BP, Hamlyn JM. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am J Physiol Regul Integr Comp Physiol (2006) 290(3):R553-9. doi:10.1152/ajpregu.00648.2005
195. Wang JG, Staessen JA, Messaggio E, Nawrot T, Fagard R, Hamlyn JM, et al. Salt, endogenous ouabain and blood pressure interactions in the general population. J Hypertens (2003) 21(8):1475-81. doi:10.1097/00004872-200308000-00010
196. Hamlyn JM, Manunta P. Endogenous ouabain: a link between sodium intake and hypertension. Curr Hypertens Rep (2011) 13(1):14-20. doi:10.1007/s11906-010-0161-z
197. Manunta P, Maillard M, Tantardini C, Simonini M, Lanzani C, Citterio L, et al. Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension. J Hypertens (2008) 26(5):914-20. doi:10.1097/HJH.0b013e3282f5315f
198. Bauer N, Müller-Ehmsen J, Krämer U, Hambarchian N, Zobel C, Schwinger RH, et al. Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of beta-blockade and angiotensin-converting enzyme inhibition. Hypertension (2005) 45(5):1024-8. doi:10.1161/01.HYP.0000165024.47728.f7
199. Bignami E, Casamassima N, Frati E, Messagio E, Corno L, Zangrillo A, et al. Endogenous ouabain changes rapidly during cardiac pulmonary by pass. J Steroids Horm Sci (2011) S3:002. doi:10.4172/2157-7536.S3-002
200. Bignami E, Casamassima N, Frati E, Lanzani C, Corno L, Alfieri O, et al. Preoperative endogenous ouabain predicts acute kidney injury in cardiac surgery patients. Crit Care Med (2013) 41(3):744-55. doi:10.1097/CCM.0b013e3182741599